Skip to search formSkip to main contentSkip to account menu

3 ML Insulin Glargine 100 UNT/ML Pen Injector [Lantus]

Known as: Lantus 300 UNT per 3 ML OptiClik Pen, Lantus 300 UNT per 3 ML SoloStar Pen, INSULIN GLARGINE 100 [iU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [Lantus] 
National Institutes of Health

Related topics

Related topics

9 relations
GlycerinHydrochloric AcidInsulin GlargineLantus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Allergie aux insulines avec tests cutanés positifs : à propos d’un cas
2011
2011
Basalog® is similar to Lantus® in producing glycemic control in patients with type 1 diabetes mellitus on multiple daily insulin regimens
This study was performed to compare the insulin glargine produced by two different manufacturers. The study determines the… 
2009
2009
Seguridad de Insulina Glargina (Lantus ®): (Nota informativa de la AEMPS 2009/09, de 29 de junio de 2009)
En relacion con los datos publicados en la revista Diabetologia1 sobre la posible asociacion entre el uso de la insulina glargina… 
2008
2008
Insulin delivery with FlexPen®: dose accuracy, patient preference and adherence
The introduction of insulin pens has helped improve adherence in Type 1 or 2 diabetes, and reduce inaccurate dosing, fear of… 
2008
2008
P157 Qualité de vie des diabétiques tunisiens insulinotraités
2007
2007
Tratamiento con Glargina (Lantus®) a un grupo de adolescents
2006
2006
Comparison of Infusion Resistance of Commercial Insulin Injectors with that for Infusion using Special Injection Needles, and Cautions in Instructing Patients on Injection Technique
Owing to the large infusion resistance of insulin injectors, instruction on self injection is sometimes difficult for diabetes… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)